Although metagenomic sequencing has provided unprecedented characterization of the gut microbiome, it gives only indirect evidence of the genes and pathways that might be active. Now, investigators have combined longitudinal sampling with metatranscriptomics and metagenomics in IBD to provide a high-resolution picture of the microbiome's functional dynamics.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Analysis and Interpretation of metagenomics data: an approach
Biological Procedures Online Open Access 19 November 2022
-
Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
Journal of Translational Medicine Open Access 13 December 2019
-
A crash course in sequencing for a microbiologist
Journal of Applied Genetics Open Access 25 January 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
The Human Microbiome Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
Schirmer, M. et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol. https://doi.org/10.1038/s41564-017-0089-z (2018).
Schloissnig, S. et al. Genomic variation landscape of the human gut microbiome. Nature 493, 45–50 (2013).
Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382–392 (2014).
Bang, S. et al. Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation. Br. J. Pharmacol. 166, 1433–1443 (2012).
Franzosa, E. A. et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl Acad. Sci. USA 111, E2329–E2338 (2014).
Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.S. is co-founder of Nextbiotix and has served as consultant for BiomX, Danone, Enterome and Maat pharma. A.L. declares no competing interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lavelle, A., Sokol, H. Beyond metagenomics, metatranscriptomics illuminates microbiome functionality in IBD. Nat Rev Gastroenterol Hepatol 15, 193–194 (2018). https://doi.org/10.1038/nrgastro.2018.15
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2018.15
This article is cited by
-
Analysis and Interpretation of metagenomics data: an approach
Biological Procedures Online (2022)
-
Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis
Journal of Gastrointestinal Surgery (2020)
-
Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
Journal of Translational Medicine (2019)
-
A crash course in sequencing for a microbiologist
Journal of Applied Genetics (2019)